MAWATARI Seiichi 馬渡誠一

… Alternative Names

Mawatari Seiichi 馬渡誠一

Less

Researcher Number	50735339
Other IDs
Affiliation (Current)	2026: 鹿児島大学, 医歯学域医学系, 講師
Affiliation (based on the past Project Information) *help	2022 – 2023: 鹿児島大学, 医歯学域医学系, 講師 2018 – 2021: 鹿児島大学, 医歯学域医学系, 助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related
Keywords	Principal Investigator 臓器連関 / 膵酵素 / 膵機能低下 / アルコール / STAMマウス / 脂肪肝 / エタノール / HCV / NS5A共変異 / NS5B … More / SOF/LDV / 直接作用型抗ウイルス薬 / C型肝炎ウイルス / 薬剤耐性変異 Less

Research Projects
(2 results)
Research Products
(14 results)

Analysis of organ interactions in alcoholic liver diseasePrincipal Investigator
- Principal Investigator
  
  Mawatari Seiichi
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Kagoshima University
Analysis of novel resistance-associated substitutions of direct-acting antivirals for hepattis C virusPrincipal Investigator
- Principal Investigator
  
  Mawatari Seiichi
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Kagoshima University

All 2022 2021 2020 2019 2018

All Journal Article Presentation

[Journal Article] Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus2022
- Author(s)
  Mawatari S, Kumagai K, Oda K, Tabu K, Ijuin S, Fujisaki K, Tashima S, Inada Y, Uto H, Saisyoji A, Hiramine Y, Hashiguchi M, Tamai T, Hori T, Taniyama O, Toyodome A, Sakae H, Kure T, Sakurai K, Moriuchi A, Kanmura S, Ido A.
- Journal Title
  
  PLoS One.
  
  Volume: 17(1) Issue: 1 Pages: e0262267-e0262267
- DOI
  10.1371/journal.pone.0262267
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16001
[Journal Article] Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD2022
- Author(s)
  Ijuin S, Oda K, Mawatari S, Taniyama O, Toyodome A, Sakae H, Tabu K, Kumagai K, Kanmura S, Tamai T, Moriuchi A, Uto H, Ido A.
- Journal Title
  
  Mol Clin Oncol.
  
  Volume: 16(2) Issue: 2 Pages: 55-55
- DOI
  10.3892/mco.2021.2488
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16001
[Journal Article] Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma2022
- Author(s)
  Mawatari S, Tamai T, Kumagai K, Saisyoji A, Muromachi K, Toyodome A, Taniyama O, Sakae H, Ijuin S, Tabu K, Oda K, Hiramine Y, Moriuchi A, Sakurai K, Kanmura S, Ido A.
- Journal Title
  
  Cancers
  
  Volume: 14（24） Issue: 24 Pages: 6139-6139
- DOI
  10.3390/cancers14246139
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16001
[Journal Article] Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all‐oral direct antiviral therapy2020
- Author(s)
  Mawatari Seiichi、Oda Kohei、Kumagai Kotaro、Tabu Kazuaki、Ijuin Sho、Fujisaki Kunio、Inada Yukiko、Uto Hirofumi、Saisyoji Akiko、Hiramine Yasunari、Hori Takeshi、Taniyama Ohki、Toyodome Ai、Sakae Haruka、Hashiguchi Masafumi、Kure Takeshi、Sakurai Kazuhiro、Tamai Tsutomu、Moriuchi Akihiro、Ido Akio
- Journal Title
  
  Hepatology Research
  
  Volume: 50 Issue: 4 Pages: 453-465
- DOI
  10.1111/hepr.13474
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K15821
[Journal Article] Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals2020
- Author(s)
  Tabu K、Mawatari S、Oda K、Kumagai K、Inada Y、Uto H、Saisyoji A、Hiramine Y、Hashiguchi M、Tamai T、Hori T、Fujisaki K、Imanaka D、Kure T、Taniyama O、Toyodome A、Ijuin S、Sakae H、Sakurai K、Moriuchi A、Kanmura S、Ido A
- Journal Title
  
  PLOS ONE
  
  Volume: 15 Issue: 8 Pages: e0237475-e0237475
- DOI
  10.1371/journal.pone.0237475
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15821
[Journal Article] The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir2018
- Author(s)
  Mawatari Seiichi、Oda Kohei、Tabu Kazuaki、Ijuin Sho、Kumagai Kotaro、Fujisaki Kunio、Hashiguchi Masafumi、Inada Yukiko、Uto Hirofumi、Hiramine Yasunari、Kure Takeshi、Hori Takeshi、Taniyama Oki、Kasai Ai、Tamai Tsutomu、Moriuchi Akihiro、Ido Akio
- Journal Title
  
  PLOS ONE
  
  Volume: 13 Issue: 6 Pages: e0198642-e0198642
- DOI
  10.1371/journal.pone.0198642
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] Clinical effect of Lenvatinib-TACE therapy in patients with BCLC-intermediate stage hepatocellular carcinoma2022
- Author(s)
  Seiichi Mawatari, Tsutomu Tamai, Akiko Saisyoji, Ai Toyodome, Oki Taniyama, Haruka Sakae, Sho Ijuin, Kazuaki Tabu, Kohei Oda, Kotaro Kumagai, Yasunari Hiramine, Akihiro Moriuchi, Kazuhiro Sakurai, Akio Ido
- Organizer
  APASL2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K16001
[Presentation] DAA治療不成功例の経過と不成功に関連する因子の検討2021
- Author(s)
  馬渡誠一、池田正徳、井戸章雄
- Organizer
  日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-21K16001
[Presentation] DAA再治療不成功例における薬剤耐性変異の検討2020
- Author(s)
  馬渡誠一、池田正徳、井戸章雄
- Organizer
  JDDW2020
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] DAA 治療不成功例の特徴と再治療効果.2019
- Author(s)
  馬渡誠一,森内昭博, 井戸章雄.
- Organizer
  第105回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] SOF/LDV治療不成功に関連する因子の解析2018
- Author(s)
  馬渡誠一、森内昭博、井戸章雄
- Organizer
  日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] DAAs治療非著効に関連する薬剤耐性変異の検討2018
- Author(s)
  馬渡誠一、森内昭博、井戸章雄
- Organizer
  JDDW2018
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] DAAs治療不成功に関連する薬剤耐性変異の解析2018
- Author(s)
  馬渡誠一、森内昭博、井戸章雄
- Organizer
  日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-18K15821
[Presentation] NS5A and NS5B resistance-associated substitutions are associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir2018
- Author(s)
  Seiichi Mawatari, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kotaro Kumagai , Shuzo Tashima, Ai Kasai, Tsutomu Tamai, Akihiro Moriuchi , Akio Ido
- Organizer
  UEGW2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15821

MAWATARI Seiichi 馬渡 誠一

Mawatari Seiichi 馬渡 誠一

Research Projects

Research Products

Analysis of organ interactions in alcoholic liver diseasePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of novel resistance-associated substitutions of direct-acting antivirals for hepattis C virusPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all‐oral direct antiviral therapy2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] Clinical effect of Lenvatinib-TACE therapy in patients with BCLC-intermediate stage hepatocellular carcinoma2022

Author(s)

Organizer

Data Source

[Presentation] DAA治療不成功例の経過と 不成功に関連する因子の検討2021

Author(s)

Organizer

Data Source

[Presentation] DAA再治療不成功例における薬剤耐性変異の検討2020

Author(s)

Organizer

Data Source

[Presentation] DAA 治療不成功例の特徴と再治療効果.2019

Author(s)

Organizer

Data Source

[Presentation] SOF/LDV治療不成功に関連する因子の解析2018

Author(s)

Organizer

Data Source

[Presentation] DAAs治療非著効に関連する薬剤耐性変異の検討2018

Author(s)

Organizer

Data Source

[Presentation] DAAs治療不成功に関連する薬剤耐性変異の解析2018

Author(s)

Organizer

Data Source

[Presentation] NS5A and NS5B resistance-associated substitutions are associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir2018

Author(s)

Organizer

Data Source

MAWATARI Seiichi 馬渡誠一

Mawatari Seiichi 馬渡誠一

[Presentation] DAA治療不成功例の経過と不成功に関連する因子の検討2021